Spectral AI Q2 Earnings Call Highlights

Spectral AI, Inc. (NASDAQ: MDAI) reported second-quarter results reflecting a transition toward commercial operations following the U.S. Food and Drug Administration’s De Novo clearance of its DeepView System for burn assessment in May. The company reiterated its 2026 revenue guidance of approximately $18.5 million, which excludes anticipated significant revenue from DeepView system sales.
Second-quarter financial results showed research and development revenue declined to $3.5 million fr